Invention Grant
- Patent Title: Fusion proteins and combination vaccines comprising Haemophilus influenzae protein E and pilin A
-
Application No.: US15197952Application Date: 2016-06-30
-
Publication No.: US10214569B2Publication Date: 2019-02-26
- Inventor: Normand Blais , Steve Labbe , Jan Poolman
- Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Agent Barbara J. Carter
- Main IPC: C07K14/285
- IPC: C07K14/285 ; A61K39/102 ; A61K39/00
Abstract:
The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
Public/Granted literature
- US20170029472A1 FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A Public/Granted day:2017-02-02
Information query
